These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36212952)

  • 1. NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/
    Zhou J; Lai J; Cheng Y; Qu W
    Evid Based Complement Alternat Med; 2022; 2022():1890823. PubMed ID: 36212952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEK2 is associated with poor prognosis of clear cell renal cell carcinoma and promotes tumor cell growth and metastasis.
    Feng X; Jiang Y; Cui Y; Xu Y; Zhang Q; Xia Q; Chen Y
    Gene; 2023 Jan; 851():147040. PubMed ID: 36370999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEK2 promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through the Wnt/β-catenin signaling pathway.
    Guo D; Yao W; Du X; Dong J; Zhang X; Shen W; Zhu S
    Discov Oncol; 2023 May; 14(1):80. PubMed ID: 37233832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of NEK2 is correlated with poor prognosis in human clear cell renal cell carcinoma.
    Wang C; Huang Y; Ma X; Wang B; Zhang X
    Int J Immunopathol Pharmacol; 2021; 35():20587384211065893. PubMed ID: 34910592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
    Huang JL; Liao Y; Qiu MX; Li J; An Y
    Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/
    Zhang P; Xu Y; Chen S; Wang Z; Zhao L; Chen C; Kang W; Han R; Qiu J; Wang Q; Gao H; Wu G; Xia Q
    J Oncol; 2022; 2022():2724515. PubMed ID: 35774359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
    Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
    Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9876715. PubMed ID: 37476339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Expression of NEK2, JMJD4, and REST in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical, Pathological, and Prognostic Findings.
    Elsayed WSH; Harb OA; Alabiad MA; Faraj Saad RH; Anbaig A; Alorini M; Hemeda R; Negm M; Gertallah LM; Abdelhady WA; Ali RM
    Iran J Pathol; 2023; 18(2):180-192. PubMed ID: 37600577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of SDHA inhibited proliferation, migration, and invasion of clear cell renal cell carcinoma cells via inactivation of the Wnt/β-catenin pathway.
    Xu X; Zhang N; Gao R; Wang J; Dai Z; Bi J
    J Recept Signal Transduct Res; 2022 Apr; 42(2):180-188. PubMed ID: 33602019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
    Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
    Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX2 interacts with SCD1 and activates Wnt/β-catenin signaling pathway to promote the progression of clear cell renal cell carcinoma.
    Song X; Liu J; Liu B; Piao C; Kong C; Li Z
    Cancer Med; 2023 Mar; 12(5):5764-5780. PubMed ID: 36200301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling.
    Lu J; Wei JH; Feng ZH; Chen ZH; Wang YQ; Huang Y; Fang Y; Liang YP; Cen JJ; Pan YH; Liao B; Chen WF; Chen W; Luo JH
    Oncotarget; 2017 Mar; 8(13):21461-21471. PubMed ID: 28423523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway.
    Wang Q; Xu J; Xiong Z; Xu T; Liu J; Liu Y; Chen J; Shi J; Shou Y; Yue C; Liu D; Liang H; Yang H; Yang X; Zhang X
    J Transl Med; 2021 Oct; 19(1):417. PubMed ID: 34627268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-138 induces cell survival and reduces WNT/β-catenin signaling of osteoarthritis chondrocytes through NEK2.
    Xu W; Gao P; Zhang Y; Piao L; Dong D
    IUBMB Life; 2019 Sep; 71(9):1355-1366. PubMed ID: 31034758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD56 polysialylation promotes the tumorigenesis and progression via the Hedgehog and Wnt/β-catenin signaling pathways in clear cell renal cell carcinoma.
    Jian Y; Zhang L; Gong L; Ding M; Sun X; Yu X; Lv S; Li J; Yang D; Wang S
    Cancer Cell Int; 2023 Dec; 23(1):319. PubMed ID: 38087309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
    Xu Y; Wu G; Zhang J; Li J; Ruan N; Zhang J; Zhang Z; Chen Y; Zhang Q; Xia Q
    Biomed Res Int; 2020; 2020():8409239. PubMed ID: 32908919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX17 Antagonizes the WNT Signaling Pathway and is Epigenetically Inactivated in Clear-Cell Renal Cell Carcinoma.
    Wang L; Wang Z; Zhu Y; Tan S; Chen X; Yang X
    Onco Targets Ther; 2021; 14():3383-3394. PubMed ID: 34079284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00675 suppresses proliferative, migration and invasion of clear cell renal cell carcinoma via the Wnt/β-catenin pathway.
    Zhu L; Liu XL; Fu ZQ; Qiu P; Feng T; Yan B; Wei JL
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2313-2320. PubMed ID: 32196582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.